# Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

> **NCT06676852** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Hematopoietic Cell Transplant
- Hematologic Malignancy

## Interventions

- **BEHAVIORAL:** Primary palliative care

## Key facts

- **NCT ID:** NCT06676852
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06676852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06676852, "Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06676852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*